IRB Advisor – January 1, 2015
January 1, 2015
View Issues
-
Participant recruitment can pose challenges from ethical perspective
Federal regulations require researchers to maintain an equitable selection of participants, and IRBs take this into consideration when reviewing study protocols. But what are the ethical implications when a study has difficulty recruiting or retaining subjects? From an IRB perspective, recruitment must not be coercive, but how can researchers ensure participants are truly willing volunteers in small studies that require a major physical commitment? -
New SACHRP board member explains goals, HRP advocacy
IRB Advisor asked Diana T. Chingos, MS, MFA, executive director of the Noreen Fraser Foundation in Los Angeles, to tell readers a little more about herself and her hopes and goals for the Secretarys Advisory Committee on Human Research Protections (SACHRP), to which she was appointed in October 2014. -
Researchers punt subject complaints to IRB — but then what do you do?
Its a long-standing issue with IRBs: Studies are approved, participants are enrolled, study interventions and visits occur and someone complains. But then what? -
Find the right CBPR training for your IRB
Community-based participatory research (CBPR) brings members of the community into a study as partners who are involved with subject recruitment, study design, informed consent, and other aspects of research. Community partners can include tribal councils, religious organizations, neighborhood groups, and other social organizations. -
NIH proposes tougher clinical trial reporting requirements
The agencys Notice of Proposed Rulemaking (NPRM), released in November, expands clinical trial registration and reporting guidelines for clinical trials that are required to register with ClinicalTrials.gov under the U.S. Food and Drug Administration Amendments Act (FDAAA). -
Research participants’ social media use can compromise study’s validity
Blogs, message boards, and patient communities are being used not only by patients, but also by research participants. In some cases, this reveals whether or not a participant is taking actual medication or placebos, compromising the studys validity.